{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:08:08Z","timestamp":1787162888046,"version":"build-2736575974"},"reference-count":203,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.critrevonc.2022.103626","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T02:18:53Z","timestamp":1644459533000},"page":"103626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["BRCA1\/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning"],"prefix":"10.1016","volume":"172","author":[{"given":"Daniele","family":"Fanale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Pivetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cancelliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Spera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Fiorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Pedone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Barraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Brando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tancredi Didier Bazan","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Vieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girolamo","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2022.103626_bib1","article-title":"Predicting functional effect of human missense mutations using PolyPhen\u20102","volume":"76","author":"Adzhubei","year":"2014","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.critrevonc.2022.103626_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10689-014-9747-y","article-title":"Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations","volume":"14","author":"Ahlborn","year":"2014","journal-title":"Famil. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10549-015-3313-7","article-title":"Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic","volume":"150","author":"Ahlborn","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/jmedgenet-2011-100305","article-title":"Clinical impact of unclassified variants of the BRCA1 and BRCA2 genes","volume":"48","author":"Akbari","year":"2011","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib6","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions","volume":"98","author":"Antoniou","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3390\/genes10110882","article-title":"The BRCA1c.4096+3A>G variant displays classical characteristics of pathogenic BRCA1 mutations in hereditary breast and ovarian cancers, but still allows homozygous viability","volume":"10","author":"Arason","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.critrevonc.2022.103626_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejim.2016.03.010","article-title":"Mutation detection rates associated with specific selection criteria for BRCA1\/2 testing in 1854 high-risk families: a monocentric Italian study","volume":"32","author":"Azzollini","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib9","doi-asserted-by":"crossref","first-page":"10678","DOI":"10.1093\/nar\/gkz784","article-title":"CSB interacts with BRCA1 in late S\/G2 to promote MRN- and CtIP-mediated DNA end resection","volume":"47","author":"Batenburg","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10897-012-9547-1","article-title":"NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer","volume":"22","author":"Berliner","year":"2012","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.critrevonc.2022.103626_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/humu.20210","article-title":"UMD (Universal mutation database): 2005 update","volume":"26","author":"B\u00e9roud","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41525-020-00158-5","article-title":"A computational model for classification of BRCA2 variants using mouse embryonic stem cell-based functional assays","volume":"5","author":"Biswas","year":"2020","journal-title":"npj Genom. Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-13-243","article-title":"Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)","volume":"13","author":"Blay","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/nar\/gkg095","article-title":"The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003","volume":"31","author":"Boeckmann","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cancergencyto.2006.05.005","article-title":"RNA-based analysis of BRCA1 and BRCA2 gene alterations","volume":"170","author":"Bonatti","year":"2006","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100235","article-title":"Impact of deleterious variants in other genes beyond BRCA1\/2 detected in breast\/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge","volume":"6","author":"Bono","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.critrevonc.2022.103626_bib17","doi-asserted-by":"crossref","first-page":"E1200","DOI":"10.1002\/humu.21202","article-title":"Characterization ofBRCA1andBRCA2deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study","volume":"31","author":"Borg","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib18","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.str.2004.06.002","article-title":"Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains","volume":"12","author":"Botuyan","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.critrevonc.2022.103626_bib19","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2010.28.0784","article-title":"Evaluation of the tyrer-cuzick (international breast cancer intervention study) model for breast cancer risk prediction in women with atypical hyperplasia","volume":"28","author":"Boughey","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review Cancer Biology & Medicine","volume":"14","author":"Brett","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10549-017-4552-6","article-title":"BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation","volume":"167","author":"Brianese","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib22","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1093\/nar\/gkm402","article-title":"Aberrant 5\u2032 splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization","volume":"35","author":"Buratti","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib23","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ccr3.944","article-title":"Classification of the spliceogenic BRCA1c.4096+3A>G variant as likely benign based on cosegregation data and identification of a healthy homozygous carrier","volume":"5","author":"Byrjalsen","year":"2017","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.critrevonc.2022.103626_bib24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-0004.2012.01933.x","article-title":"TheBRCA1S1715N mutation segregates with breast and ovarian cancer in an extended family pedigree","volume":"83","author":"Campbell","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2107-6","article-title":"Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast\/ovarian cancer","volume":"16","author":"Cao","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.biocel.2006.08.002","article-title":"Functional assays for BRCA1 and BRCA2","volume":"39","author":"Carvalho","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib27","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","article-title":"Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes","volume":"22","author":"Cast\u00e9ra","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/humu.21414","article-title":"EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients","volume":"32","author":"Caux-Moncoutier","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-014-0121-3","article-title":"Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?","volume":"6","author":"Cheon","year":"2014","journal-title":"Genome Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib30","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e60","article-title":"The influence of BRCA variants of unknown significance on cancer risk management decision-making","volume":"30","author":"Chern","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib31","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e80","article-title":"Clinical significance of variants of unknown significances in BRCA genes","volume":"30","author":"Choi","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/IGC.0000000000001161","article-title":"Unclassified Variants of BRCA1 and BRCA2 in Korean patients with Ovarian cancer","volume":"28","author":"Choi","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib33","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","article-title":"PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels","volume":"31","author":"Choi","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.critrevonc.2022.103626_bib34","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10897-017-0072-0","article-title":"Risk perception and psychological distress in genetic counselling for hereditary breast and\/or ovarian cancer","volume":"26","author":"Cicero","year":"2017","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.critrevonc.2022.103626_bib35","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1200\/JCO.2017.76.2781","article-title":"Evaluation of a streamlined oncologist-led BRCA mutation testing and counseling model for patients with ovarian cancer","volume":"36","author":"Colombo","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10549-017-4275-8","article-title":"Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome","volume":"164","author":"Concolino","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib37","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.3390\/ijms20143442","article-title":"BRCA1 and BRCA2 testing through next generation sequencing in a small cohort of italian breast\/ovarian cancer patients: novel pathogenic and unknown clinical significance variants","volume":"20","author":"Concolino","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2022.103626_bib38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/gtmb.2009.0183","article-title":"A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis.","volume":"14","author":"Coulet","year":"2010","journal-title":"Genet. Test. Mol. Biomark."},{"key":"10.1016\/j.critrevonc.2022.103626_bib39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.biocel.2006.08.005","article-title":"Specific changes in the proteomic pattern produced by the BRCA1-Ser1841Asn missense mutation","volume":"39","author":"Crugliano","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/cge.12097","article-title":"Variants of uncertain significance inBRCAtesting: evaluation of surgical decisions, risk perception, and cancer distress","volume":"84","author":"Culver","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.critrevonc.2022.103626_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/15384047.2015.1108494","article-title":"Absence of germlineCDKN2Amutation in Sicilian patients with familial malignant melanoma: could it be a population-specific genetic signature?","volume":"17","author":"Di Lorenzo","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.critrevonc.2022.103626_bib43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<465::AID-IJC5>3.0.CO;2-4","article-title":"BRCA1 mutation analysis in 83 Spanish breast and breast\/ovarian cancer families","volume":"83","author":"D\u00edez","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.lungcan.2018.05.027","article-title":"Germline mutations in young non-smoking women with lung adenocarcinoma","volume":"122","author":"Donner","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10549-014-2845-6","article-title":"Estimating risks for variants of unknown significance according to their predicted pathogenicity classes with application to BRCA1","volume":"144","author":"Dowty","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib46","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/521032","article-title":"A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer\u2013predisposition genes","volume":"81","author":"Easton","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1934-1","article-title":"Understanding of BRCA VUS genetic results by breast cancer specialists","volume":"15","author":"Eccles","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib48","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/annonc\/mdv278","article-title":"BRCA1 and BRCA2 genetic testing \u2013 pitfalls and recommendations for managing variants of uncertain clinical significance","volume":"26","author":"Eccles","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib49","article-title":"BRCA challenge: BRCA exchange as a global resource for variants in BRCA1 and BRCA2","volume":"14","author":"Eng","year":"2018","journal-title":"PLOS Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib50","doi-asserted-by":"crossref","DOI":"10.1186\/s12920-018-0353-y","article-title":"Performance of in silico prediction tools for the classification of rare BRCA1\/2 missense variants in clinical diagnostics","volume":"11","author":"Ernst","year":"2018","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.critrevonc.2022.103626_bib51","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3390\/cancers11101454","article-title":"A functional analysis of the unclassified Pro2767Ser BRCA2 variant reveals its potential pathogenicity that acts by hampering DNA binding and homology-mediated DNA repair","volume":"11","author":"Esposito","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2022.103626_bib52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-013-2583-1","article-title":"Contralateral mastectomy improves survival in women with BRCA1\/2-associated breast cancer","volume":"140","author":"Evans","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib53","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc2054","article-title":"Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations","volume":"7","author":"Fackenthal","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib54","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/onc.2011.408","article-title":"Breast cancer genome-wide association studies: there is strength in numbers","volume":"31","author":"Fanale","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2022.103626_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/746858","article-title":"Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines","volume":"2013","author":"Fanale","year":"2013","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.critrevonc.2022.103626_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.827822","article-title":"Impact of different selection approaches for identifying lynch syndrome-related colorectal cancer patients: unity is strength","volume":"12","author":"Fanale","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib57","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1517\/14728222.2014.920324","article-title":"Germline copy number variation in theYTHDC2gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?","volume":"18","author":"Fanale","year":"2014","journal-title":"Exp. Opin. Therap. Targets"},{"key":"10.1016\/j.critrevonc.2022.103626_bib58","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3390\/cancers12092415","article-title":"Detection of germline mutations in a Cohort of 139 patients with bilateral breast cancer by multi-gene panel testing: impact of pathogenic variants in other genes beyond BRCA1\/2","volume":"12","author":"Fanale","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2022.103626_bib59","first-page":"65","author":"Fanale","year":"2021","journal-title":"Hered. Cancers Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.682445","article-title":"Prevalence and spectrum of germline BRCA1 and BRCA2 variants of uncertain significance in breast\/ovarian cancer: mysterious signals from the genome","volume":"11","author":"Fanale","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103597","article-title":"Can the tumor-agnostic evaluation of MSI\/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?","volume":"170","author":"Fanale","year":"2022","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-020-01554-6","article-title":"Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers","volume":"39","author":"Federici","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib63","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib64","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1074\/jbc.RA118.005274","article-title":"Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: implications for clinical annotation","volume":"294","author":"Fernandes","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2022.103626_bib65","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/bioinformatics\/bti486","article-title":"PMUT: a web-based tool for the annotation of pathological mutations on proteins","volume":"21","author":"Ferrer-Costa","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.critrevonc.2022.103626_bib66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-018-0461-z","article-title":"Accurate classification of BRCA1 variants with saturation genome editing","volume":"562","author":"Findlay","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2022.103626_bib67","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/genes11080925","article-title":"Prevalence and spectrum of BRCA germline variants in central italian high risk or familial breast\/ovarian cancer patients: a monocentric study","volume":"11","author":"Foglietta","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.critrevonc.2022.103626_bib68","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/humu.21438","article-title":"LOVD v.2.0: the next generation in gene variant databases","volume":"32","author":"Fokkema","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib69","first-page":"2321","article-title":"A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer","volume":"11","author":"Forbes","year":"2019","journal-title":"Cancer Manag.\u00a0Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib70","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/jclinpath-2020-206800","article-title":"Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS Network","volume":"74","author":"Fumagalli","year":"2021","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib71","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1042\/BJ20141077","article-title":"Protein stability versus function: effects of destabilizing missense mutations on BRCA1 DNA repair activity","volume":"466","author":"Gaboriau David","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.critrevonc.2022.103626_bib72","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s10897-016-9993-2","article-title":"Family studies for classification of variants of uncertain classification: current laboratory clinical practice and a new web-based educational tool","volume":"25","author":"Garrett","year":"2016","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.critrevonc.2022.103626_bib73","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ng1295-428","article-title":"Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype\u2013phenotype correlation","volume":"11","author":"Gayther","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10689-005-2579-z","article-title":"Insights into the molecular basis of human hereditary breast cancer from studies of the BRCA1 BRCT domain","volume":"5","author":"Glover","year":"2006","journal-title":"Famil. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib75","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/424388","article-title":"Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2","volume":"75","author":"Goldgar","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib76","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/humu.20897","article-title":"Genetic evidence and integration of various data sources for classifying uncertain variants into a single model","volume":"29","author":"Goldgar","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib77","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2919","article-title":"Rare variants in the ATMgene and risk of breast cancer","volume":"13","author":"Goldgar","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib78","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2223","article-title":"A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2genes based on cancer family history","volume":"11","author":"G\u00f3mez Garc\u00eda","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib79","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.critrevonc.2019.05.012","article-title":"Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives","volume":"140","author":"Gori","year":"2019","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib80","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.7150\/jca.30410","article-title":"BRCA genes: the role in genome stability, cancer stemness and therapy resistance","volume":"10","author":"Gorodetska","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib81","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3422-2","article-title":"Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers","volume":"17","author":"Grindedal","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/humu.22478","article-title":"Functional assays for analysis of variants of uncertain significance inBRCA2","volume":"35","author":"Guidugli","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib83","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ajhg.2017.12.013","article-title":"Assessment of the clinical relevance of BRCA2 missense variants by functional and computational approaches","volume":"102","author":"Guidugli","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib84","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e83","article-title":"Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers","volume":"31","author":"Ha","year":"2020","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib85","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41436-018-0018-4","article-title":"Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models","volume":"21","author":"Hart","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib86","first-page":"2020","article-title":"Sensitivity and specificity of loss of heterozygosity analysis for the classification of rare germline variants in BRCA1\/2: results of the observational AGO-TR1 study (NCT02222883)","author":"Hauke","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib87","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/humu.20894","article-title":"Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance","volume":"29","author":"Hofstra","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib88","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/humu.22101","article-title":"Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico\/in vitro studies on BRCA1 and BRCA2 variants","volume":"33","author":"Houdayer","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib89","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1158\/0008-5472.CAN-07-6189","article-title":"A syngeneic variance library for functional annotation of human variation: application to BRCA2","volume":"68","author":"Hucl","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib90","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0921-8777(00)00034-3","article-title":"The BRCA1C-terminal domain: structure and function","volume":"460","author":"Huyton","year":"2000","journal-title":"Mutat. Res.\/DNA Rep."},{"key":"10.1016\/j.critrevonc.2022.103626_bib91","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4098-y","article-title":"Male BRCA mutation carriers: clinical characteristics and cancer spectrum","volume":"18","author":"Ibrahim","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib92","article-title":"BRCA1\/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype\u2013phenotype correlation in a cohort of 531 patients.","volume":"12","author":"Incorvaia","year":"2020","journal-title":"Therap. Adv. Med. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib93","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/cancers12051158","article-title":"Hereditary breast and ovarian cancer in families from Southern Italy (Sicily) \u2013 Prevalence and geographic distribution of pathogenic variants in BRCA1\/2 genes","volume":"12","author":"Incorvaia","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2022.103626_bib94","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jamasurg.2017.3422","article-title":"Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations","volume":"153","author":"Jakub","year":"2018","journal-title":"JAMA Surg."},{"key":"10.1016\/j.critrevonc.2022.103626_bib95","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/gim.2013.176","article-title":"In silico tools for splicing defect prediction: a survey from the viewpoint of end users","volume":"16","author":"Jian","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib96","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1158\/0008-5472.CAN-05-1241","article-title":"Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations","volume":"65","author":"Judkins","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib97","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.mrfmmm.2004.07.024","article-title":"Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1","volume":"573","author":"Judkins","year":"2005","journal-title":"Muta. Res.\/Fundam. Mol. Mech. Mutagen."},{"key":"10.1016\/j.critrevonc.2022.103626_bib98","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3390\/ijms18020308","article-title":"Next-generation sequencing in oncology: genetic diagnosis, risk prediction and cancer classification","volume":"18","author":"Kamps","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2022.103626_bib99","doi-asserted-by":"crossref","DOI":"10.1186\/s12920-015-0115-z","article-title":"Defining \u201cmutation\u201d and \u201cpolymorphism\u201d in the era of personal genomics","volume":"8","author":"Karki","year":"2015","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.critrevonc.2022.103626_bib100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10549-010-0923-y","article-title":"No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families","volume":"125","author":"Korde","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib101","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/bjc.2011.383","article-title":"BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients","volume":"105","author":"Kote-Jarai","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib102","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1078-0432.CCR-17-2136","article-title":"Location of mutation in BRCA2 gene and survival in patients with ovarian cancer","volume":"24","author":"Labidi-Galy","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib103","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib104","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib105","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3218","article-title":"Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)","volume":"14","author":"Lecarpentier","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib106","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1158\/0008-5472.CAN-09-4563","article-title":"Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays","volume":"70","author":"Lee","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib107","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2022.103626_bib108","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijc.31601","article-title":"Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer","volume":"144","author":"Li","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib109","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","article-title":"Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature","volume":"22","author":"Liede","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/humu.21627","article-title":"A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)","volume":"33","author":"Lindor","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib111","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1634\/theoncologist.2012-0452","article-title":"BRCA1\/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management","volume":"18","author":"Lindor","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2022.103626_bib112","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-020-00412-4","article-title":"BRCA1 and homologous recombination: implications from mouse embryonic development","volume":"10","author":"Liu","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.critrevonc.2022.103626_bib113","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1200\/JCO.2010.28.7334","article-title":"Improving surveillance and quality of life ofBRCAMutation carriers","volume":"28","author":"Loman","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib114","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10086","article-title":"Patterns and functional implications of rare germline variants across 12 cancer types","volume":"6","author":"Lu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2022.103626_bib115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature13127","article-title":"Guidelines for investigating causality of sequence variants in human disease","volume":"508","author":"MacArthur","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2022.103626_bib116","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1038\/s41388-021-01984-2","article-title":"POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes","volume":"40","author":"Magrin","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2022.103626_bib117","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/gim.2018.23","article-title":"Hereditary cancer gene panel test reports: wide heterogeneity suggests need for standardization","volume":"20","author":"Makhnoon","year":"2018","journal-title":"Genet. Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib118","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jgc4.1075","article-title":"Patients' perspectives of variants of uncertain significance and strategies for uncertainty management","volume":"28","author":"Makhnoon","year":"2019","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.critrevonc.2022.103626_bib119","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.cancergencyto.2010.07.125","article-title":"Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients","volume":"203","author":"Manguo\u011flu","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2014.00148","article-title":"In silico identification of genetic variants in glucocerebrosidase (GBA) gene involved in Gaucher's disease using multiple software tools","volume":"5","author":"Manickam","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2018.00397","article-title":"Functional interaction between BRCA1 and DNA repair in yeast may uncover a role of RAD50, RAD51, MRE11A, and MSH6 somatic variants in cancer development","volume":"9","author":"Maresca","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib122","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/genes12070993","article-title":"Functional evaluation of splicing for variants of uncertain significance in patients with inherited retinal diseases","volume":"12","author":"Mauro-Herrera","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.critrevonc.2022.103626_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00388-9","article-title":"BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers","volume":"8","author":"Maxwell","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2022.103626_bib124","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/carcin\/bgn157","article-title":"An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes","volume":"29","author":"Melchor","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2022.103626_bib125","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cncr.29041","article-title":"Cancers associated withBRCA1andBRCA2mutations other than breast and ovarian","volume":"121","author":"Mersch","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib126","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41436-018-0052-2","article-title":"The functional impact of variants of uncertain significance in BRCA2","volume":"21","author":"Mesman","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib127","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/humu.9174","article-title":"Twenty-three novelBRCA1 andBRCA2 sequence alterations in breast and\/or ovarian cancer families in Southern Germany","volume":"22","author":"Meyer","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib128","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/humu.22150","article-title":"A guide for functional analysis ofBRCA1variants of uncertain significance","volume":"33","author":"Millot","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib129","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1158\/0008-5472.CAN-03-3009","article-title":"Structure-based assessment of missense mutations in human BRCA1","volume":"64","author":"Mirkovic","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/humu.22956","article-title":"Classification and clinical management of variants of uncertain significance in high penetrance cancer predisposition genes","volume":"37","author":"Moghadasi","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib131","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/hmg\/ddh095","article-title":"BRCA1:\u2005BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair","volume":"13","author":"Morris","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib132","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00432-015-1986-2","article-title":"Evaluation of BRCA1\/2 mutational status among German and Austrian women with triple-negative breast cancer","volume":"141","author":"Muendlein","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib133","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib134","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/cncr.11019","article-title":"Breast cancer genetics in African Americans","volume":"97","author":"Olopade","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ijc.10337","article-title":"Loss of heterozygosity analysis at theBRCAloci in tumor samples from patients with familial breast cancer","volume":"99","author":"Osorio","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib136","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/gtmb.2012.0381","article-title":"A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer","volume":"17","author":"Pal","year":"2013","journal-title":"Genet. Test. Mol. Biomark."},{"key":"10.1016\/j.critrevonc.2022.103626_bib137","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.3390\/cancers13184714","article-title":"Spectrum of germline pathogenic variants in BRCA1\/2 genes in the apulian southern italy population: geographic distribution and evidence for targeted genetic testing","volume":"13","author":"Patruno","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2022.103626_bib138","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2741\/4230","article-title":"The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers","volume":"19","author":"Paul","year":"2014","journal-title":"Front. Biosci."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103626_bib139","first-page":"1325","article-title":"Prophylactic mastectomy with immediate reconstruction combined with simultaneous laparoscopic salpingo-oophorectomy via a transmammary route: a novel surgical approach to female BRCA-mutation carriers","volume":"289","author":"Perab\u00f2","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/jcm9010132","article-title":"Bioinformatics and computational tools for next-generation sequencing analysis in clinical genetics","volume":"9","author":"Pereira","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib141","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/nar\/29.5.1185","article-title":"GeneSplicer: a new computational method for splice site prediction","volume":"29","author":"Pertea","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib142","article-title":"Analysis of 30 Putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction","volume":"7","author":"Peterlongo","year":"2012","journal-title":"PLOS One"},{"key":"10.1016\/j.critrevonc.2022.103626_bib143","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1016\/j.jmb.2013.08.008","article-title":"Towards precision medicine: advances in computational approaches for the analysis of human variants","volume":"425","author":"Peterson","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib144","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/1541-7786.MCR-17-0357","article-title":"Combining homologous recombination and phosphopeptide-binding data to predict the impact of BRCA1 BRCT variants on cancer risk","volume":"17","author":"Petitalot","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/10906570260199357","article-title":"Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice","volume":"6","author":"Petrucelli","year":"2002","journal-title":"Genet. Test."},{"key":"10.1016\/j.critrevonc.2022.103626_bib146","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results","volume":"29","author":"Plon","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib147","doi-asserted-by":"crossref","first-page":"4","DOI":"10.20892\/j.issn.2095-3941.2018.0055","article-title":"Next-generation sequencing and its clinical application","volume":"16","author":"Qin","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib148","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/humu.9427","article-title":"In vitro analysis of genomic instability triggered by BRCA1 missense mutations","volume":"27","author":"Quaresima","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib149","doi-asserted-by":"crossref","first-page":"i18","DOI":"10.1093\/annonc\/mdq661","article-title":"Unclassified variants in BRCA genes: guidelines for interpretation","volume":"22","author":"Radice","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10689-017-0017-7","article-title":"A comparison of cosegregation analysis methods for the clinical setting","volume":"17","author":"Ra\u00f1ola","year":"2017","journal-title":"Famil. Cancer"},{"issue":"427\u201338","key":"10.1016\/j.critrevonc.2022.103626_bib151","article-title":"The genomic landscape of endocrine-resistant advanced breast cancers","volume":"34","author":"Razavi","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2022.103626_bib152","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1524-4741.2010.01055.x","article-title":"Cancer risk management decisions of women with BRCA1 or BRCA2 variants of uncertain significance","volume":"17","author":"Ready","year":"2011","journal-title":"Breast J."},{"key":"10.1016\/j.critrevonc.2022.103626_bib153","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/humu.23406","article-title":"Mutational spectrum in a worldwide study of 29,700 families withBRCA1orBRCA2mutations","volume":"39","author":"Rebbeck","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib154","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib155","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ajhg.2021.02.005","article-title":"Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance","volume":"108","author":"Richardson","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib156","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdt312","article-title":"Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling","volume":"24","author":"Richter","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib157","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cancergen.2016.09.003","article-title":"In silico, in vitro and case-control analyses as an effective combination for analyzing BRCA1 and BRCA2 unclassified variants in a population-based sample","volume":"209","author":"Rodr\u00edguez-Balada","year":"2016","journal-title":"Cancer Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib158","doi-asserted-by":"crossref","first-page":"20080","DOI":"10.1074\/jbc.M109.088922","article-title":"Toward classification of BRCA1 missense variants using a biophysical approach","volume":"285","author":"Rowling","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2022.103626_bib159","doi-asserted-by":"crossref","first-page":"vi99","DOI":"10.1093\/annonc\/mdm235","article-title":"4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily)","volume":"18","author":"Russo","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10549-008-9906-7","article-title":"Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?","volume":"113","author":"Russo","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib161","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.critrevonc.2008.06.003","article-title":"Hereditary ovarian cancer","volume":"69","author":"Russo","year":"2009","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"issue":"109\u201316","key":"10.1016\/j.critrevonc.2022.103626_bib162","article-title":"Suggestion of BRCA1c.5339T>C (p.L1780P) variant confer from \u2018unknown significance\u2019 to \u2018Likely pathogenic\u2019 based on clinical evidence in Korea","volume":"33","author":"Ryu","year":"2017","journal-title":"The Breast"},{"key":"10.1016\/j.critrevonc.2022.103626_bib163","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.breast.2017.09.007","article-title":"Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals","volume":"36","author":"Santonocito","year":"2017","journal-title":"The Breast"},{"key":"10.1016\/j.critrevonc.2022.103626_bib164","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3390\/cancers12051286","article-title":"Spectrum of germline BRCA1 and BRCA2 variants identified in 2351 ovarian and breast cancer patients referring to a reference cancer hospital of Rome","volume":"12","author":"Santonocito","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2022.103626_bib165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.critrevonc.2022.103626_bib166","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.ejhg.5200529","article-title":"Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland","volume":"8","author":"Sarantaus","year":"2000","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib167","article-title":"Genotyping of Fanconi Anemia patients by whole exome sequencing: advantages and challenges","volume":"7","author":"Schuelke","year":"2012","journal-title":"PLOS One"},{"key":"10.1016\/j.critrevonc.2022.103626_bib168","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.critrevonc.2022.103626_bib169","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.critrevonc.2022.103626_bib170","doi-asserted-by":"crossref","DOI":"10.1186\/bcr76","article-title":"Role of BRCAgene dysfunction in breast and ovarian cancer predisposition","volume":"2","author":"Scully","year":"2000","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib171","doi-asserted-by":"crossref","first-page":"W452","DOI":"10.1093\/nar\/gks539","article-title":"SIFT web server: predicting effects of amino acid substitutions on proteins","volume":"40","author":"Sim","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib172","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jmg.2006.044388","article-title":"Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer","volume":"44","author":"Simard","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib173","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10549-010-0817-z","article-title":"Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation","volume":"125","author":"Sluiter","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib174","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/cge.13488","article-title":"Rapid reversal of clinical down-classification of a BRCA1 splicing variant avoiding psychological harm","volume":"95","author":"Smith","year":"2019","journal-title":"Clin. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib175","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12282-019-00951-w","article-title":"Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast\/ovarian cancer using the ACMG\/AMP 2015 guidelines","volume":"26","author":"So","year":"2019","journal-title":"Breast Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib176","doi-asserted-by":"crossref","first-page":"60487","DOI":"10.18632\/oncotarget.10814","article-title":"Spectrum of BRCA1\/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice","volume":"8","author":"Solano","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2022.103626_bib177","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1093\/hmg\/ddu172","article-title":"The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population","volume":"23","author":"Song","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib178","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1200\/JCO.2008.17.8228","article-title":"Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance","volume":"26","author":"Spearman","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib179","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/humu.21628","article-title":"ENIGMA-evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes","volume":"33","author":"Spurdle","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib180","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/jmedgenet-2012-101037","article-title":"BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk","volume":"49","author":"Spurdle","year":"2012","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib181","doi-asserted-by":"crossref","first-page":"55","DOI":"10.20892\/j.issn.2095-3941.2016.0002","article-title":"WR Wilcox genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing","volume":"13","author":"Stanislaw YX","year":"2016","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib182","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1534\/genetics.115.175802","article-title":"Massively parallel functional analysis of BRCA1 RING domain variants","volume":"200","author":"Starita","year":"2015","journal-title":"Genetics"},{"key":"10.1016\/j.critrevonc.2022.103626_bib183","doi-asserted-by":"crossref","DOI":"10.1002\/0471250953.bi0113s39","article-title":"The human gene mutation database (HGMD) and its exploitation in the fields of personalized genomics and molecular evolution","volume":"39","author":"Stenson","year":"2012","journal-title":"Curr. Protoc. Bioinform."},{"key":"10.1016\/j.critrevonc.2022.103626_bib184","doi-asserted-by":"crossref","first-page":"9020","DOI":"10.1093\/nar\/gkt691","article-title":"Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction","volume":"41","author":"Subramanyam","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib185","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jmb.2009.09.011","article-title":"Cancer-associated mutations in BRC domains of BRCA2 affect homologous recombination induced by Rad51","volume":"393","author":"Tal","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib186","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jmg.2005.033878","article-title":"Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral","volume":"43","author":"Tavtigian","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib187","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng0396-333","article-title":"The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds","volume":"12","author":"Tavtigian","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib188","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/humu.22213","article-title":"A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the colon cancer family registry","volume":"34","author":"Thompson","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.critrevonc.2022.103626_bib189","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","article-title":"Frequency of mutations in individuals with breast cancer referred forBRCA1andBRCA2testing using next-generation sequencing with a 25-gene panel","volume":"121","author":"Tung","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib190","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12687-015-0220-x","article-title":"Comparison of locus-specific databases for BRCA1 and BRCA2 variants reveals disparity in variant classification within and among databases","volume":"6","author":"Vail","year":"2015","journal-title":"J. Community Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib191","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/gte.2004.8.235","article-title":"Variants of uncertain clinical significance as a result of BRCA1\/2 testing: impact of an ambiguous breast cancer risk message","volume":"8","author":"Van Dijk","year":"2004","journal-title":"Genet. Test."},{"key":"10.1016\/j.critrevonc.2022.103626_bib192","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/pon.1311","article-title":"The counsellees' view of an unclassified variant in BRCA1\/2: recall, interpretation, and impact on life","volume":"17","author":"Vos","year":"2008","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.critrevonc.2022.103626_bib193","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.currproblcancer.2010.12.002","article-title":"PARP inhibitor treatment in Ovarian and breast cancer","volume":"35","author":"Weil","year":"2011","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103626_bib194","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1245\/s10434-017-5959-3","article-title":"Clinical decision-making in patients with variant of uncertain significance in BRCA1 or BRCA2 genes","volume":"24","author":"Welsh","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib195","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41594-020-00556-4","article-title":"BRCA1\/BARD1 site-specific ubiquitylation of nucleosomal H2A is directed by BARD1","volume":"28","author":"Witus","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.critrevonc.2022.103626_bib196","doi-asserted-by":"crossref","DOI":"10.1038\/npjgenmed.2016.1","article-title":"Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance.","volume":"1","author":"Woods","year":"2016","journal-title":"npj Genom. Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib197","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2022.103626_bib198","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.297.5588.1837","article-title":"BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure","volume":"297","author":"Yang","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2022.103626_bib199","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.1088753","article-title":"The BRCT domain is a phospho-protein binding domain","volume":"302","author":"Yu","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2022.103626_bib200","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/7.5.919","article-title":"Statistical features of human exons and their flanking regions","volume":"7","author":"Zhang","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.critrevonc.2022.103626_bib201","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3343\/alm.2021.41.1.25","article-title":"Application of next generation sequencing in laboratory medicine","volume":"41","author":"Zhong","year":"2021","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.critrevonc.2022.103626_bib202","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000133261","article-title":"Mechanisms of loss of heterozygosity in retinoblastoma","volume":"59","author":"Zhu","year":"1992","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.critrevonc.2022.103626_bib203","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2018.00378","article-title":"Dealing with BRCA1\/2 unclassified variants in a cancer genetics clinic: does cosegregation analysis help?","volume":"9","author":"Zuntini","year":"2018","journal-title":"Front. Genet."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822000506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822000506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:40:29Z","timestamp":1760902829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842822000506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":203,"alternative-id":["S1040842822000506"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103626","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRCA1\/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103626"}}